Endovascular treatment of brain arteriovenous malformations with prolonged intranidal Onyx injection technique: long-term results in 350 consecutive patients with completed endovascular treatment course

Clinical article

Restricted access

Object

The purpose of this study was to present the authors' clinical experience and long-term angiographic and clinical follow-up results in 350 patients with brain arteriovenous malformations (AVMs) treated using prolonged intranidal Onyx injection with a very slow “staged” reflux technique described by the authors.

Methods

Three hundred and fifty consecutive patients with brain AVMs treated using Onyx between 1999 and 2008 and in whom definitive status for endovascular treatment was reached are presented. There were 206 (59%) male and 144 (41%) female patients, with a mean age of 34 years. There were 607 endovascular sessions performed. Onyx was the only agent used for intranidal injections in all patients, but in 42 patients high-concentration N-butyl cyanoacrylate glue was used adjunctively to close high-flow direct arteriovenous intra- or perinidal fistulas, or when a feeding vessel or nidus perforation and/or dissection occurred.

Results

Angiographically confirmed obliteration was achieved in 179 patients (51%) with only endovascular treatment; 1 patient died due to intracranial hemorrhage after the treatment. Twenty-two patients underwent resection, and 136 patients were sent to radiosurgery after endovascular treatment. In 4 patients embolization therapy was discontinued, and 5 additional patients refused the suggested complementary surgery. In all 178 surviving patients who had angiographically confirmed AVM obliteration by embolization alone, 1–8 years of control angiography (mean 47 months) confirmed stable obliteration, except for 2 patients in whom a very small recruitment was noted in the 1st year on control angiography studies, despite initial apparent total obliteration (recanalization rate 1.1%). In the entire series, 5 patients died; the mortality rate was 1.4%. The permanent morbidity rate was 7.1%.

Conclusions

With the prolonged intranidal injection technique described herein, Onyx allows the practitioner to achieve higher rates of anatomical cures compared with the cure rates obtained previously with other embolic agents. More importantly, due to this technique's much more effective intranidal penetration, it allows high-grade AVMs to be made radiosurgically treatable in a group of patients for whom there has been no treatment alternative.

Abbreviations used in this paper: AP = anteroposterior; AVM = arteriovenous malformation; ICA = internal carotid artery; mRS = modified Rankin Scale; NBCA = N-butyl cyanoacrylate; PVA = polyvinyl alcohol; S-M = Spetzler-Martin; VA = vertebral artery.
Article Information

Contributor Notes

Address correspondence to: Serdar Geyik, M.D., Hacettepe University Hospitals, 06100 Sihhiye, Ankara, Turkey. email: drserdarg@hotmail.com.Please include this information when citing this paper: published online April 8, 2011; DOI: 10.3171/2011.2.JNS09830.

© AANS, except where prohibited by US copyright law.

Headings
References
  • 1

    Cekirge SSaatci IArat AOzcan OEOzgen T: Long intranidal Onyx injections in the endovascular treatment of pial brain AVMs: description of a new technique and philosophy aimed at cure. J Neurosurg 96:173A2002. (Abstract)

    • Search Google Scholar
    • Export Citation
  • 2

    Crawford PMWest CRChadwick DWShaw MD: Arteriovenous malformations of the brain: natural history in unoperated patients. J Neurol Neurosurg Psychiatry 49:1101986

    • Search Google Scholar
    • Export Citation
  • 3

    Cronqvist MWirestam RRamgren BBrandt LRomner BNilsson O: Endovascular treatment of intracerebral arteriovenous malformations: procedural safety, complications, and results evaluated by MR imaging, including diffusion and perfusion imaging. AJNR Am J Neuroradiol 27:1621762006

    • Search Google Scholar
    • Export Citation
  • 4

    Debrun GMAletich VAusman JICharbel FDujovny M: Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate. Neurosurgery 40:1121211997

    • Search Google Scholar
    • Export Citation
  • 5

    Gobin YPLaurent AMerienne LSchlienger MAymard AHoudart E: Treatment of brain arteriovenous malformations by embolization and radiosurgery. J Neurosurg 85:19281996

    • Search Google Scholar
    • Export Citation
  • 6

    Han PPPonce FASpetzler RF: Intention-to-treat analysis of Spetzler-Martin grades IV and V arteriovenous malformations: natural history and treatment paradigm. J Neurosurg 98:372003

    • Search Google Scholar
    • Export Citation
  • 7

    Haw CSterBrugge KWillinsky RTomlinson G: Complications of embolization of arteriovenous malformations of the brain. J Neurosurg 104:2262322006

    • Search Google Scholar
    • Export Citation
  • 8

    Henkes HNahser HCBerg-Dammer EWeber WLange SKühne D: Endovascular therapy of brain AVMs prior to radiosurgery. Neurol Res 20:4794921998

    • Search Google Scholar
    • Export Citation
  • 9

    Hernesniemi JADashti RJuvela SVäärt KNiemelä MLaakso A: Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery 63:8238312008

    • Search Google Scholar
    • Export Citation
  • 10

    Inci SOzcan OEBenli KSaatçi I: Microsurgical removal of a free segment of microcatheter in the anterior circulation as a complication of embolization. Surg Neurol 46:5625671996

    • Search Google Scholar
    • Export Citation
  • 11

    Jahan RMurayama YGobin YPDuckwiler GRVinters HVViñuela F: Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery 48:9849972001

    • Search Google Scholar
    • Export Citation
  • 12

    Jayaraman MVMarcellus MLDo HMChang SDRosenberg JKSteinberg GK: Hemorrhage rate in patients with Spetzler-Martin grades IV and V arteriovenous malformations: is treatment justified?. Stroke 38:3253292007

    • Search Google Scholar
    • Export Citation
  • 13

    Jungreis CAHorton JAHecht ST: Blood pressure changes in feeders to cerebral arteriovenous malformations during therapeutic embolization. AJNR Am J Neuroradiol 10:5755771989

    • Search Google Scholar
    • Export Citation
  • 14

    Katsaridis VPapagiannaki CAimar E: Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology 50:5895972008

    • Search Google Scholar
    • Export Citation
  • 15

    Laakso ADashti RSeppänen JJuvela SVäärt KNiemelä M: Long-term excess mortality in 623 patients with brain arteriovenous malformations. Neurosurgery 63:2442552008

    • Search Google Scholar
    • Export Citation
  • 16

    Morgan MKRochford AMTsahtsarlis ALittle NFaulder KC: Surgical risks associated with the management of Grade I and II brain arteriovenous malformations. Neurosurgery 61:1 Suppl4174242007

    • Search Google Scholar
    • Export Citation
  • 17

    Mounayer CHammami NPiotin MSpelle LBenndorf GKessler I: Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. AJNR Am J Neuroradiol 28:5185232007

    • Search Google Scholar
    • Export Citation
  • 18

    Murayama YViñuela FUlhoa AAkiba YDuckwiler GRGobin YP: Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile. Neurosurgery 43:116411751998

    • Search Google Scholar
    • Export Citation
  • 19

    n-BCA Trial Investigators: n-Butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial. Am J Neuroradiol AJNR 23:7487552002

    • Search Google Scholar
    • Export Citation
  • 20

    Ondra SLTroupp HGeorge EDSchwab K: The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg 73:3873911990

    • Search Google Scholar
    • Export Citation
  • 21

    Panagiotopoulos VGizewski EAsgari SRegel JForsting MWanke I: Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). AJNR Am J Neuroradiol 30:991062009

    • Search Google Scholar
    • Export Citation
  • 22

    Picard LDa Costa EAnxionnat RMacho JBracard SPer A: Acute spontaneous hemorrhage after embolization of brain arteriovenous malformation with N-butyl cyanoacrylate. J Neuroradiol 28:1471652001

    • Search Google Scholar
    • Export Citation
  • 23

    Purdy PDSamson DBatjer HHRisser RC: Preoperative embolization of cerebral arteriovenous malformations with polyvinyl alcohol particles: experience in 51 adults. AJNR Am J Neuroradiol 11:5015101990

    • Search Google Scholar
    • Export Citation
  • 24

    Spetzler RFWilson CBWeinstein PMehdorn MTownsend JTelles D: Normal perfusion pressure breakthrough theory. Clin Neurosurg 25:6516721978

    • Search Google Scholar
    • Export Citation
  • 25

    Valavanis AYaşargil MG: The endovascular treatment of brain arteriovenous malformations. Adv Tech Stand Neurosurg 24:1312141998

  • 26

    van Rooij WJSluzewski MBeute GN: Brain AVM embolization with Onyx. AJNR Am J Neuroradiol 28:1721782007

  • 27

    Weber WKis BSiekmann RKuehne D: Endovascular treatment of intracranial arteriovenous malformations with onyx: technical aspects. AJNR Am J Neuroradiol 28:3713772007

    • Search Google Scholar
    • Export Citation
  • 28

    Wikholm GLundqvist CSvendsen P: Embolization of cerebral arteriovenous malformations: Part I—Technique, morphology, and complications. Neurosurgery 39:4484591996

    • Search Google Scholar
    • Export Citation
  • 29

    Yamashita KTaki WIwata HNakahara INishi SSadato A: Characteristics of ethylene vinyl alcohol copolymer (EVAL) mixtures. AJNR Am J Neuroradiol 15:110311051994

    • Search Google Scholar
    • Export Citation
  • 30

    Zoarski GHLilly MPSperling JSMathis JM: Surgically confirmed incorporation of a chronically retained neurointerventional microcatheter in the carotid artery. AJNR Am J Neuroradiol 20:1771781999

    • Search Google Scholar
    • Export Citation
TrendMD
Cited By
Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 393 393 84
Full Text Views 243 217 6
PDF Downloads 235 215 11
EPUB Downloads 0 0 0
PubMed
Google Scholar